Last year, in the wake of the COVID-19 pandemic, Memorial Sloan Kettering Cancer Center faced a critical crossroads at which treatment for hundreds of patients hung in the balance. There was one treatment many patients desperately needed, and the pharmaceutical company that provided it was having problems with its supply chain. Eventually, representatives of that […]